Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre Study.

ABSTRACT:

Background and aims

Management of ultrasound (US)-guided percutaneous liver biopsy (PLB) lacks standardisation. Despite the low risk of major complications (< 1%), repeated blood counts and up to 4 h of in-hospital observation are typically recommended. We aimed to assess complication rates and predictors in a large cohort of patients undergoing US-PLB across three Italian tertiary centres. We included all patients undergoing US-PLB from January 2018 to December 2023. We collected clinical, biochemical and procedural features (needle type, insertions number, observation time and antiplatelet/anticoagulant regimens). Safety was assessed by the incidence of pain and major complications, including vasovagal reaction, bleeding, pneumothorax, shock, hospitalisation and death.

Approac

SUBMITTER: Colapietro F 

PROVIDER: S-EPMC11960840 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature